BDX stock · BLFS stock

BDX vs BLFS · P/E 34, rev $21.84B vs rev $56.0M

Becton Dickinson and Company (BDX) versus BioLife Solutions Inc (BLFS) — a side-by-side from cached financials, not a winner call.

Becton Dickinson and Company (BDX) is a medical instruments & supplies company listed on US.

BioLife Solutions Inc (BLFS) is a medical instruments & supplies company listed on US.

Latest reported BDX revenue for 2025-09-30 was $21.84B. Net income was $1.68B. BDX currently screens at market cap $50.30B and trailing P/E 33.9.

Latest reported BLFS revenue for 2026-06-30 was $56.0M. Net income was $46.3M. BLFS currently screens at market cap $1.05B.

BDX currently screens at market cap $50.30B and trailing P/E 33.9. BLFS currently screens at market cap $1.05B.

Not investment advice. Open the BDX and BLFS stock pages for the full models.

Not investment advice.

Popular Stock Comparisons